Trade MerckCo USA MRK

Sell
 Buy

MerckCo live chart

5m 15m 30m 1h 4h 1d 1w

instrument_fundamentals

Weekly Search
Weekly
Daily
date Close change Change (%) instr__open High Low

MerckCo news

Big Tech, Apple, Meta, Microsoft, Amazon & Alphabet
Neil Wilson 2024 Oct 24, 16:00

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Forex Indices
Bank of England, BoJ, Fed all hold policy meetings this week
Georgy Istigechev 2024 Jul 25, 16:00

Week ahead: Eurozone inflation, Fed meeting, Apple earnings

Forex Indices
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
The Bank of England
Neil Wilson 2024 Jan 25, 08:03

Week ahead: Fed, BoE to hold; Apple leads big tech earnings

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares

Latest news

Show more
Ava Grace 2025 Jul 17, 10:21

Gold Price Forecast 2025-2026: A Comprehensive Analysis by the World Gold Council

Sophia Claire 2025 Jul 17, 10:20

EU Prepares Retaliatory Measures Against US Amid Trade Dispute

Sophia Claire 2025 Jul 17, 07:20

Analyzing Trump's Tariff Threats: Are European Markets Underestimating the Risk?

Liam James 2025 Jul 17, 06:20

Iran's Khamenei: Ready for Stronger Response to Potential Attacks

Noah Lee 2025 Jul 17, 05:20

US House Advances Crypto Bill After Republican Standoff

Ava Grace 2025 Jul 17, 01:20

US Bankers Defend Federal Reserve Independence Amid Political Pressure

Noah Lee 2025 Jul 17, 01:20

US Economy in Uncertainty: Tariffs and Labor Shortages Worry Businesses

Ghko B 2025 Jul 16, 16:00

RGTI stock surged more than 22%: what’s going on with Rigetti Computing?

Stocks

Info

Spread

0.51

Spread (%)

0.6200 %

Leverage

1:10

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Thursday

13:31 - 19:59

Monday

13:31-19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Friday

13:31-19:59

instr__analysis_statistics

instr__open

---

instr__close

---

instr__52week_range

--- – ---

instr__market_cap

204699156480

instr__shares_outstand

2511030016

instr__earnings_date

2021-06-03

instr__dividend_date

2025-07-08

instr__ex_dividend_date

2025-06-16

instr__forward_annual_dividend_rate

3.24

instr__forward_annual_dividend_yield

0.0409

instr__eps

6.88

instrument_learn_more

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and ant
Markets.com Bonus Trading

related_instruments

Asset
Sell
Buy
Change (%)

trade_now_btn

trade_now_btn

trade_now_btn

trade_now_btn
view_all_instruments

latest_education_articles

Show more
Trustpilot